Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $181.71 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $87.43 | 5 | $0 (2020) |
| Amgen Inc. | $39.62 | 2 | $0 (2024) |
| Alkermes, Inc. | $24.07 | 1 | $0 (2017) |
| Grifols USA, LLC | $15.78 | 1 | $0 (2022) |
| Ferring Pharmaceuticals Inc. | $14.81 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15.59 | 1 | Amgen Inc. ($15.59) |
| 2023 | $24.03 | 1 | Amgen Inc. ($24.03) |
| 2022 | $15.78 | 1 | Grifols USA, LLC ($15.78) |
| 2020 | $53.73 | 3 | Allergan, Inc. ($38.92) |
| 2019 | $36.25 | 2 | Allergan Inc. ($36.25) |
| 2017 | $36.33 | 2 | Alkermes, Inc. ($24.07) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/14/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Cardiology | ||||||
| 12/07/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: Cardiology | ||||||
| 10/05/2022 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Immunology and Neurology | ||||||
| 09/09/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: NEUROSCIENCE | ||||||
| 06/16/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: NEUROSCIENCE | ||||||
| 01/29/2020 | Ferring Pharmaceuticals Inc. | FIRMAGON (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: UROLOGY | ||||||
| 10/03/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: NEUROSCIENCE | ||||||
| 06/05/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: NEUROSCIENCE | ||||||
| 02/01/2017 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 495 | 895 | $65,864 | $38,049 |
| 2022 | 11 | 467 | 884 | $62,848 | $38,292 |
| 2021 | 11 | 493 | 1,022 | $73,950 | $46,732 |
| 2020 | 11 | 495 | 1,094 | $73,130 | $38,038 |
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 91 | 223 | $32,525 | $19,120 | 58.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 45 | 84 | $8,995 | $5,385 | 59.9% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 52 | 103 | $5,090 | $2,009 | 39.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 14 | $2,730 | $1,953 | 71.6% |
| 86328 | Test for detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody, qualitative or semiquantitative | Office | 2023 | 37 | 44 | $2,165 | $1,923 | 88.8% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 64 | 107 | $2,175 | $1,733 | 79.7% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 41 | 94 | $1,880 | $1,525 | 81.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 21 | 21 | $3,475 | $1,321 | 38.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $2,250 | $1,115 | 49.6% |
| J1720 | Injection, hydrocortisone sodium succinate, up to 100 mg | Office | 2023 | 44 | 75 | $1,145 | $825.48 | 72.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 47 | 77 | $2,689 | $783.84 | 29.1% |
| 36410 | Insertion of needle into vein (3 years or older) | Office | 2023 | 19 | 27 | $640.00 | $354.38 | 55.4% |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | Office | 2023 | 12 | 15 | $105.00 | $0.42 | 0.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 97 | 245 | $32,953 | $22,266 | 67.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 57 | 117 | $11,610 | $7,604 | 65.5% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 48 | 99 | $4,950 | $1,867 | 37.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 29 | 29 | $4,785 | $1,780 | 37.2% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 52 | 80 | $1,600 | $1,305 | 81.6% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 29 | 66 | $1,320 | $1,072 | 81.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 53 | 85 | $2,975 | $877.92 | 29.5% |
| J1720 | Injection, hydrocortisone sodium succinate, up to 100 mg | Office | 2022 | 38 | 71 | $1,065 | $803.99 | 75.5% |
| 36410 | Insertion of needle into vein (3 years or older) | Office | 2022 | 34 | 51 | $1,275 | $634.72 | 49.8% |
| 81002 | Urinalysis, manual test | Office | 2022 | 14 | 22 | $220.00 | $75.76 | 34.4% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2022 | 16 | 19 | $95.00 | $6.13 | 6.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 102 | 292 | $39,330 | $27,751 | 70.6% |
About Dr. Ravinder Singh, M.D
Dr. Ravinder Singh, M.D is a Internal Medicine healthcare provider based in Dumfries, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/08/2007. The National Provider Identifier (NPI) number assigned to this provider is 1447308440.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ravinder Singh, M.D has received a total of $181.71 in payments from pharmaceutical and medical device companies, with $15.59 received in 2024. These payments were reported across 10 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($181.71).
As a Medicare-enrolled provider, Singh has provided services to 1,950 Medicare beneficiaries, totaling 3,895 services with total Medicare billing of $161,111. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Dumfries, VA
- Active Since 01/08/2007
- Last Updated 09/11/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1447308440
Products in Payments
- VRAYLAR (Drug) $48.51
- Repatha (Biological) $39.62
- UBRELVY (Drug) $38.92
- Aristada 441 mg (Drug) $24.07
- Gamunex-C (Biological) $15.78
- FIRMAGON (Drug) $14.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Dumfries
Dr. Kiran Patel, M.d, M.D
Internal Medicine — Payments: $2,183
Dr. Francesse Bataille, M.d, M.D
Internal Medicine — Payments: $1,608
Dr. Angela Love, Va, VA
Internal Medicine
Dr. Dylan Deardorff, M.d, M.D
Internal Medicine
Loreto Virtudes, Md, MD
Internal Medicine